PPARGC1A and early-onset autosomal dominant Alzheimer disease: In the Alzheimer’s disease model, soluble β-amyloid peptide oligomers (AβOs) prevent the PGC-1α-SIRT1 interaction, thereby decreasing the level of nuclear PGC-1α and promoting irreversible neurodegeneration [37].